Cancer Genetics (CGIX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cancer Genetics Announces Strong Second Quarter 2015 Results
August 11, 2015 7:30 AM EDTSecond Quarter Revenues up 177 Percent Year-over-Year; Six-Months Ended June 30, 2015 Revenues up 191 Percent Year-over-Year Recent Award of Largest Clinical Trial in Company's History Further Validation of CGI's Bench to Bedside Strategy Secured strategic alliance with ICON plc, a global CRO for the biopharma community Announced that it has entered into an agreement to acquire assets and operations of Response Genetics, Inc. (OTCQB: RGDX)
RUTHERFORD, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), an emerging leader in... More
Cancer Genetics Announces Strong Second Quarter 2015 Results
August 11, 2015 7:30 AM EDTSecond Quarter Revenues up 177 Percent Year-over-Year; Six-Months Ended June 30, 2015 Revenues up 191 Percent Year-over-Year Recent Award of Largest Clinical Trial in Company's History Further Validation of CGI's Bench to Bedside Strategy Secured strategic alliance with ICON plc, a global CRO for the biopharma community Announced that it has entered into an agreement to acquire assets and operations of Response Genetics, Inc. (OTCQB: RGDX)
RUTHERFORD, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), an emerging leader in... More
